Forte Biosciences: FB-401 Could Become The First Line Topical Therapy In Atopic Dermatitis Market

Published Apr 08 2021 at 10:59 PM GMT
Key
Points
  • Forte Biosciences: FB-401 Could Become The First Line Topical Therapy In Atopic Dermatitis Market.




Stats

  • Published Apr 8, 2021 10:59 PM GMT